Relmada Therapeutics, Inc. | ||||
NMS : RLMD || Location: United States | ||||
$4.65+0.06 (+1.31%) |
0.11 M | 4.5 - 4.71 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 1.752 M |
Feb. 29, 2024 | 1.754 M |
Feb. 15, 2024 | 1.735 M |
Jan. 31, 2024 | 1.607 M |
Jan. 12, 2024 | 1.564 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
09/30/2023 | -0.93 | -0.73 | 21.61% |
06/30/2023 | -0.91 | -0.84 | 8.18% |
03/31/2023 | -0.91 | -0.87 | 4.08% |
12/31/2022 | -1.35 | -1.41 | -4.12% |
09/30/2022 | -1.45 | -1.31 | 9.70% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 30.174M | Shares Float | 25.612M |
Short Float | 1.752M | Market Cap | 140.31M |
Institution ownership | 46.24% | Insider ownership | 8.240% |
Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
Trailing EPS | -3.28 | Forward EPS | -2.36 |